---
gsd_state_version: 1.0
milestone: v3.2
milestone_name: milestone
status: verifying
last_updated: "2026-06-22T16:54:36.834Z"
last_activity: 2026-06-22
progress:
  total_phases: 9
  completed_phases: 9
  total_plans: 11
  completed_plans: 11
---

# Project State

## Project Reference

See: .planning/PROJECT.md (updated 2026-06-12)

**Core value:** A working cohort filter chain that reads like a clinical protocol — with logged attrition at every step and clear payer-stratified visualizations showing how patients flow from enrollment through diagnosis to treatment.

**Current focus:** Phase 112 — add-cancer-diagnosis-temporally-to-gantt-data

## Current Position

Phase: 112
Plan: Not started
Status: Phase complete — ready for verification
Last activity: 2026-06-22

## Performance Metrics

**Milestone velocity:**

- v3.1: 4 phases (100-103) completed in 1 day (2026-06-12)
- v3.0: 5 phases (95-99) completed in 3 days (2026-06-09 to 2026-06-11)
- v2.3: 4 phases completed in 2 days

**Planning efficiency:**

- Average plans per phase: 1.0
- Average tasks per plan: 3.0
- Phase 104: 6 minutes (2 tasks)
- Phase 105: 6 minutes (3 tasks)
- Phase 106: 5 minutes (2 tasks)

## Accumulated Context

### Recent Decisions

**v3.2 Roadmap decisions:**

- Phase numbering continues from Phase 103 (v3.1 last phase) -> v3.2 starts at Phase 104
- Granularity: coarse (4 phases for 11 requirements)
- CODE-01/02/03 (small verification scripts) combined with OVERLAP-01 into single Phase 105 for coarse grouping
- TIMING-01 + TIMING-02 grouped as Phase 104 (both are treatment/diagnosis timing investigations)
- TABLE-01 + TABLE-02 grouped as Phase 106 (both are Tableau-ready output tables)
- REPORT-01/02/03 must be last phase (Phase 107) since it compiles findings from all investigations
- Phases 104, 105, 106 are independent and can be executed in any order
- Phase 107 depends on all three preceding phases

**Phase 106 decisions:**

- Comma separator for cancer codes (meeting notes line 75, not semicolons like R/57)
- Separate xlsx per table (not combined workbook) for clearer Tableau import purpose
- One row per encounter+medication in TABLE-2 (no aggregation) for Tableau pivot flexibility

**v3.1 decisions (carried forward):**

- CONDITION table as 3rd-tier cancer linkage supplement (read-only investigation pattern)
- Broadened output = primary files; linked-only with _linked_only suffix
- data.table cartesian join for temporal self-join patterns
- Raw counts without HIPAA suppression for internal investigation scripts (manual suppression before sharing)

### Roadmap Evolution

**v3.2 Structure:**

- Phase 104: Treatment Timing Investigations (TIMING-01, TIMING-02)
- Phase 105: Code & Overlap Verification (CODE-01, CODE-02, CODE-03, OVERLAP-01)
- Phase 106: Tableau-Ready Data Tables (TABLE-01, TABLE-02)
- Phase 107: Gap Resolution Report & Delivery (REPORT-01, REPORT-02, REPORT-03)

**Coverage:** 11/11 v3.2 requirements mapped (100%)

- Phase 108 added: Fix warnings that are in warnings.txt
- Phase 109 added: Fix co-administration analysis: remove ICD9 codes that blur single-agent detection and switch grouping from encounter to date
- Phase 110 added: redo cancer_summary_table_pre_post_v2_7day.xlsx but have it so only Confirmed (7-Day Gap) HL pts are in it and rows k through l only have Confirmed (7-Day Gap) respective malignancies
- Phase 111 added: For chemo_drugs_by_class.xlsx combine agents by date per ID, collapse agents into one string for each date
- Phase 112 added: Add cancer diagnosis temporally to Gantt data and enforce alphabetical ordering in abbreviated/condensed lists

### Open Questions

None currently identified.

### Active TODOs

- [x] Plan Phase 104 (Treatment Timing Investigations) - radiation before HL dx + secondary malignancy table
- [x] Plan Phase 105 (Code & Overlap Verification) - Ethna/transplant/SCT codes + HL+NHL overlap
- [x] Plan Phase 106 (Tableau-Ready Data Tables) - encounter-level cancer codes and chemo drugs
- [ ] Plan Phase 107 (Gap Resolution Report) - RMarkdown report + manifest + meeting notes update

### Known Blockers

None identified.

## Session Continuity

**Last command:** `/gsd:execute-phase 106` (Phase 106 execution)
**What's next:** Plan Phase 107 via `/gsd:plan-phase 107`

### Recent Changes

- 2026-06-15: Phase 106 complete (Tableau-Ready Data Tables - TABLE-01/TABLE-02)
- 2026-06-15: Phase 105 complete (Code & Overlap Verification - CODE-01/02/03, OVERLAP-01)
- 2026-06-15: Phase 104 complete (Treatment Timing Investigations - TIMING-01/02)
- 2026-06-15: v3.2 roadmap created with 4 phases (104-107) covering 11 requirements
- 2026-06-12: v3.1 milestone completed (Phases 100-103, 4 phases, 9 requirements)
- 2026-06-12: Phase 103 complete (death date cross-tab summary)
- 2026-06-12: Phase 102 complete (co-administration analysis)
- 2026-06-12: Phase 101 complete (broadened drug grouping output)
- 2026-06-12: Phase 100 complete (CONDITION table cancer linkage)

### Key Files Modified

**v3.2 Roadmap Creation:**

- Overwritten: .planning/ROADMAP.md (v3.2 roadmap replacing v3.1 content)
- Updated: .planning/STATE.md (v3.2 milestone tracking)
- Updated: .planning/REQUIREMENTS.md (traceability section with phase mappings)

### Outstanding Work

**Immediate (v3.2):**

- Phase 104: Treatment timing investigations (2 requirements) — COMPLETE
- Phase 105: Code & overlap verification (4 requirements) — COMPLETE
- Phase 106: Tableau-ready data tables (2 requirements) — COMPLETE
- Phase 107: Gap resolution report & delivery (3 requirements)

**Deferred from v3.0:**

- Phase 98 Plan 02: R/98 validation script and R/88 full smoke test (1 of 2 plans pending)

---
*State updated: 2026-06-15 after Phase 106 completion*
